These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 21996173)

  • 1. Fifty years in the vineyard of transplantation: looking back.
    Kahan BD
    Transplant Proc; 2011 Oct; 43(8):2853-9. PubMed ID: 21996173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forty years of publication of transplantation proceedings--the second decade: the cyclosporine revolution.
    Kahan BD
    Transplant Proc; 2009 Jun; 41(5):1423-37. PubMed ID: 19545653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance.
    Semiltova N; Shen XD; Fishbein MC; Gao F; Slomowitz SJ; Jiao Q; Mukherjee K; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplantation; 2003 Feb; 75(4):550-3. PubMed ID: 12605125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
    Semiletova NV; Shen XD; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005 May; 37(4):1937-9. PubMed ID: 15919510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic transplantation in miniature swine: III. Induction of tolerance by transplantation of composite thymokidneys across fully major histocompatibility complex-mismatched barriers.
    Yamada K; Vagefi PA; Utsugi R; Kitamura H; Barth RN; LaMattina JC; Sachs DH
    Transplantation; 2003 Aug; 76(3):530-6. PubMed ID: 12923439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
    Kahan BD
    Transplant Proc; 2008 Dec; 40(10 Suppl):S17-20. PubMed ID: 19100899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish experience with cyclosporine.
    Pascual J; Marcén R; Burgos FJ; Villafruela JJ; Teruel JL; Mampaso F; Quereda C; Ortuño J
    Transplant Proc; 2004 Mar; 36(2 Suppl):117S-119S. PubMed ID: 15041319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of early tolerance regulator genes induced by allochimeric therapy using microarray-based genomewide scan.
    Liu D; Shen XD; Fang Z; Gao F; Semiletova N; Cao MJ; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005 May; 37(4):1942-3. PubMed ID: 15919512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction in clinical transplantation.
    Fehr T; Sykes M
    Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
    Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
    Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.